GDTC — CytoMed Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for CytoMed Therapeutics, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	PROSPECTUS/A	20-F
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.371	0.885	2.51	1.58
Net Total Receivables	0	0.012	0.005	0.058
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.544	1.47	3.28	2.49
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.34	2.3	2.5	2.47
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	2.92	3.82	6.08	5.23
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.373	2.73	2.94	4.17
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.998	3.34	3.49	4.64
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.92	0.476	2.59	0.587
Total Liabilities & Shareholders' Equity	2.92	3.82	6.08	5.23
Total Common Shares Outstanding